Exact Mass: 335.0592

Exact Mass Matches: 335.0592

Found 222 metabolites which its exact mass value is equals to given mass value 335.0592, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

S-Formylglutathione

(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-(formylsulfanyl)ethyl]carbamoyl}butanoic acid

C11H17N3O7S (335.0787)


S-Formylglutathione, also known as L-gamma-glutamyl-S-formyl-L-cysteinylglycine, belongs to the class of organic compounds known as oligopeptides. These are organic compounds containing a sequence of three to ten alpha-amino acids joined by peptide bonds. S-Formylglutathione is a very strong basic compound (based on its pKa). S-Formylglutathione exists in all living species, ranging from bacteria to humans. Outside of the human body, S-formylglutathione has been detected, but not quantified in, several different foods, such as sweet marjorams, muscadine grapes, amaranths, lemon verbena, and garden tomato. This could make S-formylglutathione a potential biomarker for the consumption of these foods. S-Formylglutathione is formed from the oxidation of S-hydroxymethylglutathione by the enzyme formaldehyde dehydrogenase (FDH; EC 1.2.1.1) in the presence of NAD (PMID: 2806555). S-Formylglutathione is formed from the oxidation of S-hydroxymethylglutathione by the enzyme formaldehyde dehydrogenase (FDH; EC 1.2.1.1) in the presence of NAD (PubMed ID 2806555) [HMDB]. S-Formylglutathione is found in many foods, some of which are horseradish tree, wild carrot, japanese walnut, and red beetroot.

   

Dihydroneopterin phosphate

[(2R,3S)-3-(2-amino-4-oxo-1,4,7,8-tetrahydropteridin-6-yl)-2,3-dihydroxypropoxy]phosphonic acid

C9H14N5O7P (335.0631)


Dihydroneopterin phosphate is involved in the folate biosynthesis pathway. Dihydroneopterin phosphate is produced from 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine. triphosphate by [E3.6.1.-]. Dihydroneopterin phosphate is then converted to Dihydroneopterin by [E3.6.1.-]. Dihydroneopterin phosphate is involved in the folate biosynthesis pathway. Dihydroneopterin phosphate is produced from 2-Amino-4-hydroxy-6-(erythro-1,2,3-trihydroxypropyl)dihydropteridine

   
   

Zoxamide

Pesticide4_Zoxamide_C14H16Cl3NO2_3,5-Dichloro-N-(1-chloro-3-methyl-2-oxopentan-3-yl)-4-methylbenzamide

C14H16Cl3NO2 (335.0247)


   

sulfanitran

sulfanitran

C14H13N3O5S (335.0576)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent D000890 - Anti-Infective Agents > D013424 - Sulfanilamides

   

7,8-Dihydroneopterin 2-phosphate

7,8-Dihydroneopterin 2-phosphate

C9H14N5O7P (335.0631)


   

Nicotinate mononucleotide

nicotinic acid mononucleotide

C11H14NO9P (335.0406)


   

Oxonantenine

18,19-dimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0²,¹⁰.0⁴,⁸.0¹⁶,²⁰]icosa-1(20),2,4(8),9,12,14,16,18-octaen-11-one

C19H13NO5 (335.0794)


Alkaloid from Laurelia sempervirens (Peruvian nutmeg). Oxonantenine is found in custard apple, cherimoya, and herbs and spices. Oxonantenine is found in cherimoya. Oxonantenine is an alkaloid from Laurelia sempervirens (Peruvian nutmeg).

   

S-formylglutathionate(1-)

2-amino-4-({1-[(carboxymethyl)-C-hydroxycarbonimidoyl]-2-(formylsulfanyl)ethyl}-C-hydroxycarbonimidoyl)butanoic acid

C11H17N3O7S (335.0787)


S-formylglutathionate(1-) is considered to be slightly soluble (in water) and acidic

   

8-Oxycoptisine

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁵,²³.0¹⁶,²⁰]tetracosa-1(24),2,4(8),9,15,20,22-heptaen-14-one

C19H13NO5 (335.0794)


   

MEK1-2-inhibitor

3-[(4-aminophenyl)sulfanyl]-3-imino-2-[2-(trifluoromethyl)phenyl]propanenitrile

C16H12F3N3S (335.0704)


   

3-(Phosphonomethyl)-5-phenyl-D-phenylalanine

(+)-alpha-Amino-3-(5-phosphonomethyl-[1.1-biphenyl]-3-yl) propanoic acid

C16H18NO5P (335.0923)


   

Flamprop-methyl

methyl 2-[N-(3-chloro-4-fluorophenyl)-1-phenylformamido]propanoate

C17H15ClFNO3 (335.0724)


   

Hapten A

3-{[methoxy(3-methyl-4-(methylsulfanyl)phenoxy)sulfanylidene-lambda5-phosphanyl]amino}propanoic acid

C12H18NO4PS2 (335.0415)


   

isoxicam

4-hydroxy-2-methyl-N-(5-methyl-2,3-dihydro-1,2-oxazol-3-ylidene)-1,1-dioxo-2H-1λ⁶,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

C11H14NO9P (335.0406)


   

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulphonic acid

C14H9NO7S (335.01)


   

Pirifibrate

(6-(Hydroxymethyl)-2-pyridyl)methyl-2-(4-chlorophenoxy)-2-methyl-propionate hydrochloride

C17H18ClNO4 (335.0924)


   

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-methyl-N-(5-methyl-1,2-oxazol-3-yl)-1,1,4-trioxo-3,4-dihydro-2H-1lambda6,2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


   

(Z)-3-Amino-3-(4-aminophenylthio)-2-(2-(trifluoromethyl)phenyl)acrylonitrile

3-amino-3-[(4-aminophenyl)sulfanyl]-2-[2-(trifluoromethyl)phenyl]prop-2-enenitrile

C16H12F3N3S (335.0704)


   

Sulotroban

2-[4-(2-Benzenesulphonamidoethyl)phenoxy]acetic acid

C16H17NO5S (335.0827)


   

2-Methyl-furan-3-carbothioic acid [4-chloro-3-(3-methyl-but-2-enyloxy)-phenyl]-amide

2-chloro-5-(((2-Methyl-3-furanyl)carbonothioyl)amino)phenyl 3-methyl-2-butenyl ether

C17H18ClNO2S (335.0747)


   

Progabide acid

4-{[(4-chlorophenyl)(5-fluoro-2-hydroxyphenyl)methylidene]amino}butanoic acid

C17H15ClFNO3 (335.0724)


D002491 - Central Nervous System Agents > D000927 - Anticonvulsants

   

caffeoylshikimate

4-{3-[(3-carboxy-5,6-dihydroxycyclohex-3-en-1-yl)oxy]-3-oxoprop-1-en-1-yl}-2-hydroxybenzen-1-olic acid

C16H15O8 (335.0767)


Caffeoylshikimate is also known as caffeoylshikimic acid. Caffeoylshikimate is slightly soluble (in water) and a weakly acidic compound (based on its pKa). Caffeoylshikimate can be found in a number of food items such as swamp cabbage, green zucchini, hazelnut, and wax gourd, which makes caffeoylshikimate a potential biomarker for the consumption of these food products.

   

S-sulfanylglutathione

[1-carboxylato-3-({1-[(carboxylatomethyl)carbamoyl]-2-disulfanylethyl}carbamoyl)propyl]azaniumyl

C10H13N3O6S2 (335.0246)


S-sulfanylglutathione is a member of the class of compounds known as oligopeptides. Oligopeptides are organic compounds containing a sequence of between three and ten alpha-amino acids joined by peptide bonds. S-sulfanylglutathione is slightly soluble (in water) and a moderately acidic compound (based on its pKa). S-sulfanylglutathione can be found in a number of food items such as oil-seed camellia, apple, rapini, and angelica, which makes S-sulfanylglutathione a potential biomarker for the consumption of these food products.

   
   

Dicentrinone

Dicentrinone

C19H13NO5 (335.0794)


D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059004 - Topoisomerase I Inhibitors D004791 - Enzyme Inhibitors

   

Oxocrebanine

8,9-Dimethoxyliriodenine

C19H13NO5 (335.0794)


   

8-Oxycoptisine

5,7,17,19-tetraoxa-13-azahexacyclo[11.11.0.02,10.04,8.015,23.016,20]tetracosa-1(24),2,4(8),9,15(23),16(20),21-heptaen-14-one

C19H13NO5 (335.0794)


8-Oxocoptisine is a natural product found in Thalictrum delavayi, Fumaria indica, and other organisms with data available. 8-Oxocoptisine is a natural protoberberine alkaloid with anti-cancer activity[1]. 8-Oxocoptisine is a natural protoberberine alkaloid with anti-cancer activity[1].

   
   
   
   

Osobuxifoline

Osobuxifoline

C19H13NO5 (335.0794)


   

N-Formyldehydroovigerine

N-Formyldehydroovigerine

C19H13NO5 (335.0794)


   
   

isoxicam

isoxicam

C14H13N3O5S (335.0576)


A monocarboxylic acid amide that is piroxicam in which the pyrid-2-yl group is replaced by a 5-methyl-1,2-oxazol-3-yl group. A non-steroidal anti-inflammatory drug, it was withdrawn from the market in the 1980s following its association with cases of Stevens-Johnson syndrome. C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents

   

Fenamiphos sulfone

Fenamiphos sulfone

C13H22NO5PS (335.0956)


CONFIDENCE standard compound; EAWAG_UCHEM_ID 3703

   

N-[4-(Cyanomethyl)phenyl]-N-[4-(trifluoromethoxy)phenyl]urea

N-[4-(Cyanomethyl)phenyl]-N-[4-(trifluoromethoxy)phenyl]urea

C16H12F3N3O2 (335.0882)


   
   
   

5(6)-1(2H)-Phthalazinonyl-4(1H)-benzimidazole-2-carbamate methyl ester

5(6)-1(2H)-Phthalazinonyl-4(1H)-benzimidazole-2-carbamate methyl ester

C17H13N5O3 (335.1018)


   
   

Neoascorbigen

Neoascorbigen

C16H17NO7 (335.1005)


   

6,13-Dihydro-7H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-on|6,13-dihydro-7H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-one|dihydro-norsanguinarinone|N-Demethyl-5,6-dihydrooxysanguinarine

6,13-Dihydro-7H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-on|6,13-dihydro-7H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4,5:4,5]benzo[1,2-c]phenanthridin-14-one|dihydro-norsanguinarinone|N-Demethyl-5,6-dihydrooxysanguinarine

C19H13NO5 (335.0794)


   

Oxo-O-methylbulbocapnine

Oxo-O-methylbulbocapnine

C19H13NO5 (335.0794)


   

OXODISCOGUATTINE

OXODISCOGUATTINE

C19H13NO5 (335.0794)


   
   

2-C-(4-methoxyindol-3-ylmethyl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone|4-methoxyascorbigen

2-C-(4-methoxyindol-3-ylmethyl)-beta-L-xylo-3-hexulofuranosonic acid gamma-lactone|4-methoxyascorbigen

C16H17NO7 (335.1005)


   

2-acetamido-3-(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoylthio)propanoic acid|JBIR-69

2-acetamido-3-(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoylthio)propanoic acid|JBIR-69

C13H21NO7S (335.1039)


   

O1-(6-amino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Amino-[2]naphthyl)-beta-D-glucopyranuronsaeure

O1-(6-amino-[2]naphthyl)-beta-D-glucopyranuronic acid|O1-(6-Amino-[2]naphthyl)-beta-D-glucopyranuronsaeure

C16H17NO7 (335.1005)


   

7-Formyldehydroovigerine

7-Formyldehydroovigerine

C19H13NO5 (335.0794)


   

11-Oxotetrodotoxin

11-Oxotetrodotoxin

C11H17N3O9 (335.0965)


   
   
   

Oxocrebanin

15,16-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.02,6.08,20.014,19]icosa-1(20),2(6),7,9,11,14(19),15,17-octaen-13-one

C19H13NO5 (335.0794)


8H-Benzo(g)-1,3-benzodioxolo(6,5,4-de)quinolin-8-one, 9,10-dimethoxy- is a natural product found in Xylopia aethiopica, Stephania hainanensis, and other organisms with data available.

   

nicotinic acid mononucleotide

[(2R,3S,4R,5R)-5-(3-Carboxypyridin-1-ium-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate

C11H14NO9P (335.0406)


Acquisition and generation of the data is financially supported in part by CREST/JST.

   
   
   
   
   

Deamido-NMN

3-carboxy-1-[(2R,3R,4S,5R)-5-[(hydrogen phosphonatooxy)methyl]-3,4-dihydroxyoxolan-2-yl]-2,3-dihydro-1$l^{5}-pyridin-1-ylium

C11H14NO9P (335.0406)


   

CAY10443

(1S)-2,3-dihydro-1H-inden-1-yl ester [(3,4-dichlorophenyl)methyl]-carbamic acid

C17H15Cl2NO2 (335.048)


   

Oxonantenine

18,19-dimethoxy-5,7-dioxa-13-azapentacyclo[10.7.1.0^{2,10}.0^{4,8}.0^{16,20}]icosa-1(19),2,4(8),9,12(20),13,15,17-octaen-11-one

C19H13NO5 (335.0794)


An oxoaporphine alkaloid isolated from Annona glabra and has been shown to exhibit acetylcholinesterase inhibitory activity.

   

beta-Nicotinamide D-ribonucleotide

1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-3-(C-hydroxycarbonimidoyl)-1$l^{5}-pyridin-1-ylium

C11H16N2O8P (335.0644)


   

4-(4-chloro-3,5-dimethylphenoxy)-N-hydroxy-3-nitrobenzenecarboximidamide

4-(4-chloro-3,5-dimethylphenoxy)-N-hydroxy-3-nitrobenzenecarboximidamide

C15H14ClN3O4 (335.0673)


   
   

n-methyl-4-(p-formylstyryl)pyridinium methylsulfate

n-methyl-4-(p-formylstyryl)pyridinium methylsulfate

C16H17NO5S (335.0827)


   

[(3R)-1-(3-fluorophenyl)pyrrolidin-3-yl] 4-methylbenzenesulfonate

[(3R)-1-(3-fluorophenyl)pyrrolidin-3-yl] 4-methylbenzenesulfonate

C17H18FNO3S (335.0991)


   

gadolinium(3+),propan-2-olate

gadolinium(3+),propan-2-olate

C9H21GdO3 (335.0732)


   

(4-Bromophenyl)(4-trifluoromethylpiperidin-1-yl)methanone

(4-Bromophenyl)(4-trifluoromethylpiperidin-1-yl)methanone

C13H13BrF3NO (335.0133)


   

6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt

6-(p-Toluidino)-2-naphthalenesulfonic acid sodium salt

C17H14NNaO3S (335.0592)


   

Sulotroban

Sulotroban

C16H17NO5S (335.0827)


C78275 - Agent Affecting Blood or Body Fluid > C1327 - Antiplatelet Agent D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents D050299 - Fibrin Modulating Agents

   

C.I. Disperse Blue 106 press cake

C.I. Disperse Blue 106 press cake

C14H17N5O3S (335.1052)


   

6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

6-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569)


   

8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

8-FLUORO-2-(3-(TRIFLUOROMETHYL)PHENYL)QUINOLINE-4-CARBOXYLIC ACID

C17H9F4NO2 (335.0569)


   

Fluorescent brightener 121

Fluorescent brightener 121

C15H14ClN3O2S (335.0495)


   

N-(4-Bromophenyl)-1,1-diphenylmethanimine

N-(4-Bromophenyl)-1,1-diphenylmethanimine

C19H14BrN (335.031)


   

Adenosine,2-(trifluoromethyl)- (7CI,8CI,9CI)

Adenosine,2-(trifluoromethyl)- (7CI,8CI,9CI)

C11H12F3N5O4 (335.0841)


   

2-chloro-4-nitrophenyl-beta-d-galactopyranoside

2-chloro-4-nitrophenyl-beta-d-galactopyranoside

C12H14ClNO8 (335.0408)


   

6-AMINO-2-CHLORO-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OLHYDROCHLORIDE

6-AMINO-2-CHLORO-6,7,8,9-TETRAHYDRO-5H-BENZOCYCLOHEPTEN-5-OLHYDROCHLORIDE

C18H19ClFNO2 (335.1088)


   

(+/-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

(+/-)-N,N-DIMETHYL-1-FERROCENYLETHYLAMINE

C16H18BrNO2 (335.0521)


   

Acridine,6-chloro-2-methoxy-9-phenoxy-

Acridine,6-chloro-2-methoxy-9-phenoxy-

C20H14ClNO2 (335.0713)


   

3-Bromo-9-(4-methylphenyl)-9H-carbazole

3-Bromo-9-(4-methylphenyl)-9H-carbazole

C19H14BrN (335.031)


   

Amlodipine besilate impurity G

Amlodipine besilate impurity G

C17H18ClNO4 (335.0924)


   

4-(BROMO-METHOXYCARBONYL-METHYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

4-(BROMO-METHOXYCARBONYL-METHYL)-PIPERIDINE-1-CARBOXYLIC ACID TERT-BUTYL ESTER

C13H22BrNO4 (335.0732)


   

BIS-(4-NITROPHENYL)PHENYLAMINE

BIS-(4-NITROPHENYL)PHENYLAMINE

C18H13N3O4 (335.0906)


   

SL-327

alpha-[Amino[(4-aminophenyl)thio]methylene]-2-(trifluoromethyl)benzeneacetonitrile

C16H12F3N3S (335.0704)


SL327 inhibits MEK1 and MEK2, with IC50 values of 180 nM and 220 nM, respectively.

   

4-AMINO-6-PHENYLPYRIMIDINE

4-AMINO-6-PHENYLPYRIMIDINE

C16H14ClNO5 (335.056)


   

7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

7-Chloro-6-fluoro-1-(4-fluorophenyl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid

C16H8ClF2NO3 (335.0161)


   

1-(4-cyanophenyl)-5-(4-methylsulfanylphenyl)pyrazole-3-carboxylic acid

1-(4-cyanophenyl)-5-(4-methylsulfanylphenyl)pyrazole-3-carboxylic acid

C18H13N3O2S (335.0728)


   

3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid

3-carboxy-5-(4-chlorobenzoyl)-1,4-dimethyl-1H-pyrrole-2-acetic acid

C16H14ClNO5 (335.056)


   

(2R,3S,4S,5S,6R)-2-(2-CHLORO-4-NITROPHENOXY)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

(2R,3S,4S,5S,6R)-2-(2-CHLORO-4-NITROPHENOXY)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL

C12H14ClNO8 (335.0408)


   

4-Chloro-7-fluoro-6-[2-(4-morpholinyl)ethoxy]-3-quinolinecarbonit rile

4-Chloro-7-fluoro-6-[2-(4-morpholinyl)ethoxy]-3-quinolinecarbonit rile

C16H15ClFN3O2 (335.0837)


   

2-(2,4-Dichlorophenyl)-α-methyl-6-benzoxazoleacetic acid

2-(2,4-Dichlorophenyl)-α-methyl-6-benzoxazoleacetic acid

C16H11Cl2NO3 (335.0116)


   
   

2-Chloro-4-nitrophenyl α-D-glucopyranoside

2-Chloro-4-nitrophenyl α-D-glucopyranoside

C12H14ClNO8 (335.0408)


   

3,4-Difluoro-N-(6-nitro-2-benzothiazolyl)benzamide

3,4-Difluoro-N-(6-nitro-2-benzothiazolyl)benzamide

C14H7F2N3O3S (335.0176)


   

(4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

(4-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)


   

5-Bromo-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

5-Bromo-1-methyl-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole

C15H19BBrNO2 (335.0692)


   

3,5-bis(trifluoromethyl)benzenesulfonyl guanidine

3,5-bis(trifluoromethyl)benzenesulfonyl guanidine

C9H7F6N3O2S (335.0163)


   

N-[4-(TRIFLUOROMETHYL)BENZOYL]-L-METHIONINYL HYDRAZIDE

N-[4-(TRIFLUOROMETHYL)BENZOYL]-L-METHIONINYL HYDRAZIDE

C13H16F3N3O2S (335.0915)


   

2,3-dimethylbenzothiazolium p-toluenesulphonate

2,3-dimethylbenzothiazolium p-toluenesulphonate

C16H17NO3S2 (335.065)


   

chlordiazepoxide hydrochloride

chlordiazepoxide hydrochloride

C16H15Cl2N3O (335.0592)


D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants > D006993 - Hypnotics and Sedatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D018377 - Neurotransmitter Agents > D018682 - GABA Agents > D018757 - GABA Modulators C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent

   
   

4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide

4-[3-(4-chlorophenyl)-4,5-dihydro-1H-pyrazol-1-yl]benzenesulphonamide

C15H14ClN3O2S (335.0495)


   

3-(5,6-dichloro-1H-indol-2-yl)-4-methoxybenzoic acid

3-(5,6-dichloro-1H-indol-2-yl)-4-methoxybenzoic acid

C16H11Cl2NO3 (335.0116)


   

2,12-DIFORMYL-DIBENZO[C,H]ACRIDINE

2,12-DIFORMYL-DIBENZO[C,H]ACRIDINE

C23H13NO2 (335.0946)


   

Pirifibrate

Pirifibrate

C17H18ClNO4 (335.0924)


C78276 - Agent Affecting Digestive System or Metabolism > C29703 - Antilipidemic Agent > C98150 - Fibrate Antilipidemic Agent

   

tris(cyclopentadienyl)cerium

tris(cyclopentadienyl)cerium

C15H15Ce (335.0228)


   

Disperse Blue 106

2-[ethyl[3-methyl-4-[(5-nitrothiazol-2-yl)azo]phenyl]amino]ethanol

C14H17N5O3S (335.1052)


   

4-(benzothiazol-2-ylazo)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one

4-(benzothiazol-2-ylazo)-2,4-dihydro-5-methyl-2-phenyl-3H-pyrazol-3-one

C17H13N5OS (335.0841)


   

8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one

8-bromo-1-[(2S)-2-methoxypropyl]-3H-imidazo[4,5-c]quinolin-2-one

C14H14BrN3O2 (335.0269)


   

Febuxostat dicarboxylic acid impurity

Febuxostat dicarboxylic acid impurity

C16H17NO5S (335.0827)


   

9-benzyl-2-bromo-9H-carbazole

9-benzyl-2-bromo-9H-carbazole

C19H14BrN (335.031)


   

4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester

4-[(2,2-Dimethyl-4,6-dioxo-[1,3]dioxan-5-ylidenemethyl)-amino]-2-methoxy-benzoic acid methyl ester

C16H17NO7 (335.1005)


   

DISPERSE BLUE 102

DISPERSE BLUE 102

C14H17N5O3S (335.1052)


   

n-[4-(trifluoromethyl)benzoyl]-l-methionine methyl ester

n-[4-(trifluoromethyl)benzoyl]-l-methionine methyl ester

C14H16F3NO3S (335.0803)


   

methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

methyl 2-bromo-3-cyclohexyl-1H-indole-6-carboxylate

C16H18BrNO2 (335.0521)


   
   

2-(Benzoyloxy)-N,N,N-trimethylethanaminium iodide

2-(Benzoyloxy)-N,N,N-trimethylethanaminium iodide

C12H18INO2 (335.0382)


   

sulfachrysoidine

sulfachrysoidine

C13H13N5O4S (335.0688)


C254 - Anti-Infective Agent > C29739 - Sulfonamide Anti-Infective Agent

   

(2-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

(2-(N-(4-Methoxybenzyl)-N-methylsulfamoyl)phenyl)boronic acid

C15H18BNO5S (335.0999)


   

N-(4-Chloro-3-((3-methyl-2-butenyl)oxy)phenyl)-2-methyl-3-furancarbothioamide

N-(4-Chloro-3-((3-methyl-2-butenyl)oxy)phenyl)-2-methyl-3-furancarbothioamide

C17H18ClNO2S (335.0747)


C471 - Enzyme Inhibitor > C1589 - Reverse Transcriptase Inhibitor > C97453 - Non-nucleoside Reverse Transcriptase Inhibitor D000890 - Anti-Infective Agents > D000998 - Antiviral Agents > D044966 - Anti-Retroviral Agents C254 - Anti-Infective Agent > C281 - Antiviral Agent

   

5-Formyl-2-deoxy-cytidine-5-monophosphate

5-Formyl-2-deoxy-cytidine-5-monophosphate

C10H14N3O8P (335.0518)


   

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid

4-Amino-1,3-dihydroxy-9,10-dioxo-9,10-dihydroanthracene-2-sulfonic acid

C14H9NO7S (335.01)


   
   
   

[4-Amino-3-(4-methylphenyl)-2-sulfanylidene-5-thiazolyl]-(4-morpholinyl)methanone

[4-Amino-3-(4-methylphenyl)-2-sulfanylidene-5-thiazolyl]-(4-morpholinyl)methanone

C15H17N3O2S2 (335.0762)


   
   

N-benzyl-3-(5-chloro-1,3-benzoxazol-2-yl)pyridin-2-amine

N-benzyl-3-(5-chloro-1,3-benzoxazol-2-yl)pyridin-2-amine

C19H14ClN3O (335.0825)


   

N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamide

N-(1,1-dioxo-3-thiolanyl)-N-(thiophen-2-ylmethyl)benzamide

C16H17NO3S2 (335.065)


   

5-[1-[(4-Fluorophenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

5-[1-[(4-Fluorophenyl)methyl]-3-pyrazolyl]-2-phenylthiazole

C19H14FN3S (335.0892)


   

N-[1-methyl-3-(trifluoromethyl)-5-thieno[2,3-c]pyrazolyl]carbamic acid 2,2-dimethylpropyl ester

N-[1-methyl-3-(trifluoromethyl)-5-thieno[2,3-c]pyrazolyl]carbamic acid 2,2-dimethylpropyl ester

C13H16F3N3O2S (335.0915)


   

N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide

N-(5,5-dimethyl-7-oxo-4,6-dihydro-1,3-benzothiazol-2-yl)-2-(2,5-dioxo-1-pyrrolidinyl)acetamide

C15H17N3O4S (335.094)


   

1-(1,3-Benzodioxol-5-ylmethylthio)-[1,2,4]triazolo[4,3-a]quinoline

1-(1,3-Benzodioxol-5-ylmethylthio)-[1,2,4]triazolo[4,3-a]quinoline

C18H13N3O2S (335.0728)


   

3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine

3-(3-aminophenyl)-N-(3-chlorophenyl)pyrazolo[1,5-a]pyrimidin-5-amine

C18H14ClN5 (335.0938)


   

2-[(Carboxycarbonyl)(1-naphthyl)amino]benzoic acid

2-[(Carboxycarbonyl)(1-naphthyl)amino]benzoic acid

C19H13NO5 (335.0794)


   

2-(Carboxymethyl)-1-Oxo-1,2-Dihydronaphtho[1,2-D]isothiazole-4-Carboxylic Acid 3,3-Dioxide

2-(Carboxymethyl)-1-Oxo-1,2-Dihydronaphtho[1,2-D]isothiazole-4-Carboxylic Acid 3,3-Dioxide

C14H9NO7S (335.01)


   

[(2S,3R,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2S,3R,4R,5R)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C11H16N2O8P+ (335.0644)


   

({[(3E)-2-Oxo-2,7-dihydro-2,3-biindol-3(7H)-ylidene]amino}oxy)acetic acid

({[(3E)-2-Oxo-2,7-dihydro-2,3-biindol-3(7H)-ylidene]amino}oxy)acetic acid

C18H13N3O4 (335.0906)


   

Nicotinamide ribotide

3-carbamoyl-1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-[(phosphonooxy)methyl]oxolan-2-yl]-1lambda5-pyridin-1-ylium

C11H16N2O8P+ (335.0644)


Nicotinamide ribotide (NMN) (CAS: 1094-61-7) is an important intermediate metabolite in the nicotinate and nicotinamide metabolism pathway. Mammals predominantly use nicotinamide rather than nicotinic acid as a precursor for NAD biosynthesis. Instead of the deamidation into nicotinic acid, nicotinamide is directly converted into NMN by nicotinamide phosphoribosyltransferase (NAMPT, EC 2.4.2.12). The enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1), which is a member of the nucleotidyltransferase alpha/beta-phosphodiesterase superfamily, catalyzes the reaction NMN + ATP <=> nicotinamide adenine dinucleotide (NAD) + PPi, representing the final step in the biosynthesis of NAD. NAD is a molecule that plays a fundamental role as a cofactor in cellular redox reactions. Thus NMN is an important metabolite for the maintenance of normal NAD biosynthesis. Circulating NMN levels may play an important role in regulating cell function in physiological and pathophysiological conditions (PMID: 15078171, 17983582). Nicotinamide ribotide (NMN) is an important intermediate metabolite in the nicotinate and nicotinamide metabolism pathway. Mammals predominantly use nicotinamide rather than nicotinic acid as a precursor for NAD biosynthesis. Instead of the deamidation to nicotinic acid, nicotinamide is directly converted to NMN by nicotinamide phosphoribosyltransferase (NAMPT, EC 2.4.2.12). The enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT, EC 2.7.7.1), a member of the nucleotidyltransferase alpha/beta-phosphodiesterase superfamily, catalyzes the reaction NMN + ATP = Nicotinamide adenine dinucleotide (NAD) + PPi, representing the final step in the biosynthesis of NAD, a molecule playing a fundamental role as a cofactor in cellular redox reactions. Thus NMN is an important metabolite for the maintenance of normal NAD biosynthesis, and circulating NMN levels may play an important role in regulating cell function in physiological and pathophysiological conditions. (PMID: 15078171, 17983582) [HMDB]

   

5-Bromo-2-(2-phenoxyethoxy)benzamide

5-Bromo-2-(2-phenoxyethoxy)benzamide

C15H14BrNO3 (335.0157)


   

5-O-Caffeoylshikimate

5-O-Caffeoylshikimate

C16H15O8- (335.0767)


   

5-Hydroxymethyldeoxycytidylate(2-)

5-Hydroxymethyldeoxycytidylate(2-)

C10H14N3O8P-2 (335.0518)


   

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10-2 (335.0852)


   

Tetracenomycin D

Tetracenomycin D

C19H11O6- (335.0556)


   

S-nitrosoglutathione(1-)

S-nitrosoglutathione(1-)

C10H15N4O7S- (335.0661)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D001993 - Bronchodilator Agents D006401 - Hematologic Agents > D010975 - Platelet Aggregation Inhibitors > D026403 - S-Nitrosothiols D002491 - Central Nervous System Agents > D018696 - Neuroprotective Agents D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents D002317 - Cardiovascular Agents > D020030 - Nitric Oxide Donors D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents D000890 - Anti-Infective Agents D020011 - Protective Agents

   

2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]imidazol-4-yl]acetate

2-[1-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(phosphonatooxymethyl)oxolan-2-yl]imidazol-4-yl]acetate

C10H12N2O9P-3 (335.028)


   

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

2-Methyl-N-(5-methyl-3-isoxazolyl)-1,1,4-trioxo-3H-1$l^{6},2-benzothiazine-3-carboxamide

C14H13N3O5S (335.0576)


   

Caffeoylshikimate

Caffeoylshikimate

C16H15O8- (335.0767)


   

[4-[3,4-Dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] hydrogen sulfate

[4-[3,4-Dihydroxy-2-(hydroxymethyl)thiolan-1-ium-1-yl]-1,3-dihydroxybutan-2-yl] hydrogen sulfate

C9H19O9S2+ (335.047)


   

4-[(1-Naphthalenylamino)-oxomethyl]benzene-1,3-dicarboxylic acid

4-[(1-Naphthalenylamino)-oxomethyl]benzene-1,3-dicarboxylic acid

C19H13NO5 (335.0794)


   

N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide

N-(2-chlorophenyl)-2-[[cyclopropyl(oxo)methyl]amino]-4-methyl-5-thiazolecarboxamide

C15H14ClN3O2S (335.0495)


   

N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide

N-(2-ethoxyphenyl)-2,1,3-benzothiadiazole-4-sulfonamide

C14H13N3O3S2 (335.0398)


   

3-(2-fluorobenzyl)-5-(1H-indol-3-ylmethylene)-2,4-imidazolidinedione

3-(2-fluorobenzyl)-5-(1H-indol-3-ylmethylene)-2,4-imidazolidinedione

C19H14FN3O2 (335.107)


   

4-[[Dimethoxyphosphoryl(phenyl)methyl]amino]benzoic acid

4-[[Dimethoxyphosphoryl(phenyl)methyl]amino]benzoic acid

C16H18NO5P (335.0923)


   

[(1S)-2,3-dihydro-1H-inden-1-yl] N-[(3,4-dichlorophenyl)methyl]carbamate

[(1S)-2,3-dihydro-1H-inden-1-yl] N-[(3,4-dichlorophenyl)methyl]carbamate

C17H15Cl2NO2 (335.048)


   

(4Z)-4-[(7-methoxy-1,3-benzodioxol-5-yl)methylidene]-2-prop-2-enylsulfanyl-1,3-thiazol-5-one

(4Z)-4-[(7-methoxy-1,3-benzodioxol-5-yl)methylidene]-2-prop-2-enylsulfanyl-1,3-thiazol-5-one

C15H13NO4S2 (335.0286)


   

N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

N-[5-[(4-chlorophenoxy)methyl]-1,3,4-thiadiazol-2-yl]-2-furancarboxamide

C14H10ClN3O3S (335.0131)


   

3-[2-(4-Aminoanilino)-4-thiazolyl]-1-benzopyran-2-one

3-[2-(4-Aminoanilino)-4-thiazolyl]-1-benzopyran-2-one

C18H13N3O2S (335.0728)


   

1-(5-Bromo-2-pyridinyl)-3-(2-methoxy-5-methylphenyl)urea

1-(5-Bromo-2-pyridinyl)-3-(2-methoxy-5-methylphenyl)urea

C14H14BrN3O2 (335.0269)


   

(R)-SKF 38393 hydrobromide

(R)-SKF 38393 hydrobromide

C16H18BrNO2 (335.0521)


   

2-(2,3-dichlorophenoxy)-N-(2,3-dihydro-1H-inden-5-yl)acetamide

2-(2,3-dichlorophenoxy)-N-(2,3-dihydro-1H-inden-5-yl)acetamide

C17H15Cl2NO2 (335.048)


   

1-(3-chloro-4-methylphenyl)-5-oxo-N-(1,3-thiazol-2-yl)pyrrolidine-3-carboxamide

1-(3-chloro-4-methylphenyl)-5-oxo-N-(1,3-thiazol-2-yl)pyrrolidine-3-carboxamide

C15H14ClN3O2S (335.0495)


   

2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide

2-(2,4-dioxo-3-thiazolidinyl)-N-[4-(4-morpholinyl)phenyl]acetamide

C15H17N3O4S (335.094)


   

4,5-Dimethoxy-2-[(1-oxo-2-thiophen-2-ylethyl)amino]benzoic acid methyl ester

4,5-Dimethoxy-2-[(1-oxo-2-thiophen-2-ylethyl)amino]benzoic acid methyl ester

C16H17NO5S (335.0827)


   

[1-(5-Phosphonatoribosyl)imidazol-4-yl]acetate(3-)

[1-(5-Phosphonatoribosyl)imidazol-4-yl]acetate(3-)

C10H12N2O9P-3 (335.028)


   

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

[4-[(E)-(pyridine-2-carbonylhydrazinylidene)methyl]phenyl] furan-2-carboxylate

C18H13N3O4 (335.0906)


   

3-(4-Methylphenyl)-5-oxo-8-thiazolo[2,3-b]quinazolinecarboxamide

3-(4-Methylphenyl)-5-oxo-8-thiazolo[2,3-b]quinazolinecarboxamide

C18H13N3O2S (335.0728)


   

5,7-dimethyl-3-[3-(trifluoromethyl)phenyl]azo-1H-pyrazolo[1,5-a]pyrimidin-2-one

5,7-dimethyl-3-[3-(trifluoromethyl)phenyl]azo-1H-pyrazolo[1,5-a]pyrimidin-2-one

C15H12F3N5O (335.0994)


   

N-[2-[(4,5-dimethyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]-4-methoxybenzohydrazide

N-[2-[(4,5-dimethyl-1,2,4-triazol-3-yl)thio]-1-oxoethyl]-4-methoxybenzohydrazide

C14H17N5O3S (335.1052)


   
   
   
   
   
   

(S)-SKF 38393 hydrobromide

(S)-SKF 38393 hydrobromide

C16H18BrNO2 (335.0521)


   

[(2R,3S,4R,5S)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

[(2R,3S,4R,5S)-5-(3-carbamoylpyridin-1-ium-1-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate

C11H16N2O8P+ (335.0644)


   

[(Z)-(7,7-dioxo-5,6-dihydrothieno[2,3-b]thiopyran-4-ylidene)amino] 2-methylbenzoate

[(Z)-(7,7-dioxo-5,6-dihydrothieno[2,3-b]thiopyran-4-ylidene)amino] 2-methylbenzoate

C15H13NO4S2 (335.0286)


   

N-[(Z)-2-chloro-1-(4-methylphenyl)sulfonylethenyl]benzamide

N-[(Z)-2-chloro-1-(4-methylphenyl)sulfonylethenyl]benzamide

C16H14ClNO3S (335.0383)


   

Fluorocyclopentenylcytosine 5-phosphate

Fluorocyclopentenylcytosine 5-phosphate

C10H11FN3O7P-2 (335.0319)


   

[7-[(3-Cyanophenyl)sulfonylamino]-4-methylindol-3-ylidene]methylideneazanide

[7-[(3-Cyanophenyl)sulfonylamino]-4-methylindol-3-ylidene]methylideneazanide

C17H11N4O2S- (335.0603)


   

S-Formylglutathione

S-Formylglutathione

C11H17N3O7S (335.0787)


A S-acylglutathione in which the acyl group specified is formyl.

   

Dihydroneopterin phosphate

Dihydroneopterin phosphate

C9H14N5O7P (335.0631)


   

beta-Nicotinamide ribose monophosphate

beta-Nicotinamide ribose monophosphate

C11H16N2O8P+ (335.0644)


   

5-[(e)-Caffeoyl]shikimate

5-[(e)-Caffeoyl]shikimate

C16H15O8 (335.0767)


A hydroxy monocarboxylic acid anion that is the conjugate base of 5-[(E)-caffeoyl]shikimic acid. Major structure at pH 7.3

   

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

(S)-malyl N-acetyl-alpha-D-glucosaminide(2-)

C12H17NO10 (335.0852)


A carbohydrate acid derivative anion obtained by deprotonation of both carboxy groups of (S)-malyl N-acetyl-alpha-D-glucosaminide; major species at pH 7.3.

   
   

7,8-Dihydroneopterin 3-phosphate

7,8-Dihydroneopterin 3-phosphate

C9H14N5O7P (335.0631)


   

7,16-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

7,16-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

C19H13NO5 (335.0794)


   

(2r)-2-[(2s)-6-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2r)-2-[(2s)-6-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)


   

1-[2-methoxy-2-(4-nitrophenyl)ethanesulfonyl]-4-methylbenzene

1-[2-methoxy-2-(4-nitrophenyl)ethanesulfonyl]-4-methylbenzene

C16H17NO5S (335.0827)


   

1-chloro-n-(2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl)methanecarbonimidoyl chloride

1-chloro-n-(2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl)methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

(5s,10r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

(5s,10r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

C18H13N3O2S (335.0728)


   

(3s)-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

(3s)-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

C18H13N3O2S (335.0728)


   

3-[(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

3-[(3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl)sulfanyl]-2-[(1-hydroxyethylidene)amino]propanoic acid

C13H21NO7S (335.1039)


   

(2s)-2-[(2r)-6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2s)-2-[(2r)-6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

C15H13NO8 (335.0641)


   

16,18-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

16,18-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

C19H13NO5 (335.0794)


   

4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,11,16,18(22)-heptaene-11-carbaldehyde

4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,11,16,18(22)-heptaene-11-carbaldehyde

C19H13NO5 (335.0794)


   

(2r)-3-{[(2s,3r)-3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

(2r)-3-{[(2s,3r)-3-hydroxy-2-isopropyl-4-methoxy-4-oxobutanoyl]sulfanyl}-2-[(1-hydroxyethylidene)amino]propanoic acid

C13H21NO7S (335.1039)


   

(3r,5s,10r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

(3r,5s,10r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

C18H13N3O2S (335.0728)


   

(3r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

(3r)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

C18H13N3O2S (335.0728)


   

4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,11,16,18(22)-heptaene-13-carbaldehyde

4,6,19,21-tetraoxa-13-azahexacyclo[10.10.1.0²,¹⁰.0³,⁷.0¹⁶,²³.0¹⁸,²²]tricosa-1(23),2(10),3(7),8,11,16,18(22)-heptaene-13-carbaldehyde

C19H13NO5 (335.0794)


   

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-23-ol

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-23-ol

C19H13NO5 (335.0794)


   

2,3-dihydroxy-3-(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)propoxyphosphonic acid

2,3-dihydroxy-3-(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)propoxyphosphonic acid

C9H14N5O7P (335.0631)


   

(3s,3as,6s,6ar)-3,3a,6-trihydroxy-3-[(1-methoxyindol-3-yl)methyl]-dihydro-5h-furo[3,2-b]furan-2-one

(3s,3as,6s,6ar)-3,3a,6-trihydroxy-3-[(1-methoxyindol-3-yl)methyl]-dihydro-5h-furo[3,2-b]furan-2-one

C16H17NO7 (335.1005)


   

1-chloro-n-[(6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

1-chloro-n-[(6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

2-[6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

2-[6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

C15H13NO8 (335.0641)


   

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-12-ol

5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-12-ol

C19H13NO5 (335.0794)


   

(2r)-17-oxa-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16(21),18-hexaene-7,15,20-trione

(2r)-17-oxa-6,14,22-triazapentacyclo[12.8.0.0²,⁶.0⁸,¹³.0¹⁶,²¹]docosa-1(22),8,10,12,16(21),18-hexaene-7,15,20-trione

C18H13N3O4 (335.0906)


   

2-[6-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

2-[6-(1-carboxyethyl)-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-2-yl]propanoic acid

C16H17NO7 (335.1005)


   

(2r,3s)-2,3-dihydroxy-3-(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)propoxyphosphonic acid

(2r,3s)-2,3-dihydroxy-3-(4-hydroxy-2-imino-7,8-dihydro-1h-pteridin-6-yl)propoxyphosphonic acid

C9H14N5O7P (335.0631)


   

16,17-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14(19),15,17-octaen-13-one

16,17-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14(19),15,17-octaen-13-one

C19H13NO5 (335.0794)


   

17,18-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

17,18-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1,6,8,10,12(20),14,16,18-octaen-13-one

C19H13NO5 (335.0794)


   

(2r)-2-[(2s)-6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

(2r)-2-[(2s)-6-(carboxymethyl)-4-hydroxy-5,7-dioxo-2h,3h-furo[2,3-f]isoindol-2-yl]propanoic acid

C15H13NO8 (335.0641)


   

15,16-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

15,16-dimethoxy-3,5-dioxa-11-azapentacyclo[10.7.1.0²,⁶.0⁸,²⁰.0¹⁴,¹⁹]icosa-1(20),2(6),7,9,11,14,16,18-octaen-13-one

C19H13NO5 (335.0794)


   

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]propanoic acid

2-[(2s)-2-[(1r)-1-carboxyethyl]-4-hydroxy-7-oxo-2h,3h,5h-furo[2,3-f]isoindol-6-yl]propanoic acid

C16H17NO7 (335.1005)


   

1-chloro-n-[(2s,6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

1-chloro-n-[(2s,6e)-2-chloro-7,11-dimethyl-3-methylidenedodeca-6,10-dien-1-yl]methanecarbonimidoyl chloride

C16H24Cl3N (335.0974)


   

(3r,5s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

(3r,5s,10s)-9-thia-11,15,20-triazaheptacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0⁵,²⁰.0¹⁷,²¹]docosa-1,7,11,14(21),16-pentaene-6,13-dione

C18H13N3O2S (335.0728)


   

(12s)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-12-ol

(12s)-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0²,¹⁰.0⁴,⁸.0¹⁴,²².0¹⁷,²¹]tetracosa-1(13),2,4(8),9,14,16,21,23-octaen-12-ol

C19H13NO5 (335.0794)


   

9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

C18H13N3O2S (335.0728)


   

(3s,10s)-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

(3s,10s)-9-thia-11,15,20-triazahexacyclo[12.6.1.1³,¹⁰.0²,¹².0³,⁸.0¹⁷,²¹]docosa-1(20),2(12),4,7,14(21),16-hexaene-6,13-dione

C18H13N3O2S (335.0728)